InvestSMART

Regeneus Ltd (ASX: RGS) - Announcements

- Current share price for RGS : $0.012

ASX company news and announcements for Regeneus Ltd (RGS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regeneus Ltd (RGS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regeneus Ltd (RGS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regeneus Ltd (RGS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$7 Progenza patent to grant in Europe 18 Oct 2018 9:11AM $0.185 $0.012 fallen by 93.51%
$7 Appendix 3Y Change of Director's Interest Notice 19 Sep 2018 10:36AM $0.165 $0.012 fallen by 92.73%
$7 Date of AGM 18 Sep 2018 8:43AM $0.165 $0.012 fallen by 92.73%
$7 Regeneus receives R&D tax incentive refund of $2.4m 6 Sep 2018 9:18AM $0.175 $0.012 fallen by 93.14%
$7 FY18 Results and Business Update 30 Aug 2018 2:32PM $0.195 $0.012 fallen by 93.85%
$7 FY18 Results and Business Update Presentation 30 Aug 2018 2:23PM $0.195 $0.012 fallen by 93.85%
$7 Appendix 4G and Corporate Governance Statement 30 Aug 2018 2:14PM $0.200 $0.012 fallen by 94%
$7 Annual Report 2018 30 Aug 2018 2:13PM $0.200 $0.012 fallen by 94%
$7 Appendix 4E 30 Aug 2018 2:11PM $0.200 $0.012 fallen by 94%
$7 Positive clinical trial results for cancer vaccine 30 Jul 2018 9:45AM $0.235 $0.012 fallen by 94.89%
$7 Appendix 4C - Quarterly 25 Jul 2018 10:00AM $0.210 $0.012 fallen by 94.29%
$7 Response to ASX Price Query 23 Jul 2018 3:03PM $0.230 $0.012 fallen by 94.78%
$7 US Patent Office to allow key patent for Progenza 10 Jul 2018 9:01AM $0.140 $0.012 fallen by 91.43%
$7 Update on licensing Progenza in Japan 3 Jul 2018 10:00AM $0.120 $0.012 fallen by 90%
$7 Grant of ASX Waiver 28 Jun 2018 11:40AM $0.120 $0.012 fallen by 90%
$7 Appendix 4C - Quarterly 26 Apr 2018 9:05AM $0.120 $0.012 fallen by 90%
$7 Appendix 3Y Change of Director's Interest Notice 20 Apr 2018 9:26AM $0.120 $0.012 fallen by 90%
$7 Positive trial results of Progenza for knee OA published 7 Mar 2018 10:55AM $0.120 $0.012 fallen by 90%
$7 Half-Year Results Presentation 20 Feb 2018 1:44PM $0.125 $0.012 fallen by 90.40%
$7 Half-Year Results Announcement 20 Feb 2018 1:43PM $0.125 $0.012 fallen by 90.40%
$7 Appendix 4D and Half-Year Report 20 Feb 2018 1:43PM $0.125 $0.012 fallen by 90.40%
$7 European Medicines Agency grants Progenza ATMP status 14 Feb 2018 9:42AM $0.125 $0.012 fallen by 90.40%
$7 Japanese Patent Office to grant patent for cancer vaccine 12 Feb 2018 9:48AM $0.115 $0.012 fallen by 89.57%
$7 Regeneus Announces Successful Results in Acne Study 6 Feb 2018 10:45AM $0.115 $0.012 fallen by 89.57%
$7 Appendix 4C - Quarterly 25 Jan 2018 8:29AM $0.115 $0.012 fallen by 89.57%

226 - 250 of 378 results

Page 10 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.